美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

避孕概念

2,832.82

+54.121.95%

漲家數：3

跌家數：2

平家數：- -

市盈率：- -

高：2,848.64

開：2,778.70

低：2,778.70

收：2,778.69

成交量：240.52萬

成交額：5,148.16萬

市值：452.82億

流通市值：422.86億

資料載入中...

總覽新聞資訊

曼恩凱德生物醫療：售股股東擬最多拋售逾1285萬股，含逾241萬份認股權證股份

市場消息：土耳其對梯瓦製藥發起反壟斷調查。

梯瓦製藥的妥瑞氏綜合徵療法獲美國FDA優先審評

梯瓦製藥的Ecopipam新藥申請獲得美國食品藥品監督管理局（FDA）優先審評資格。

Dare Bioscience 宣佈完成600萬美元註冊直接發行，按納斯達克規則市價定價

Dare Bioscience 發布2026年第二季度財報：多產品女性健康戰略推進，商業拐點凸顯

Femasys Inc：Maxim Group 將目標價從30美元下調至10美元，以反映1比20的反向股票分割

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/BK4584/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4584","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","market":"US","secType":"PLATE","nameCN":"避孕概念","latestPrice":2832.8157,"timestamp":1787673858227,"preClose":2778.6934,"halted":0,"volume":2405232,"delay":0,"changeRate":0.019478,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":54.122314,"latestTime":"08-25 12:04:20 EDT","open":2778.704,"high":2848.6401,"low":2778.704,"amount":51481632.378823,"amplitude":0.025169,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.821577,"peRate":71.768844,"turnoverRate":0.001674,"increases":3,"decrements":2,"flats":0,"marketCap":45281748556,"floatMarketCap":42286038707},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","high":2848.6401,"amplitude":0.025169,"preClose":2778.6934,"low":2778.704,"pbRate":"5.821577","latestPrice":2832.8157,"volume":2405232,"delay":0,"open":2778.704,"prevYearClose":2379.9924,"prevWeekClose":2809.5261,"prevMonthClose":2636.2712,"prevQuarterClose":2562.5076,"fiveDayClose":2752.8147,"twentyDayClose":2390.8718,"sixtyDayClose":2639.9878,"secType":"PLATE","market":"US","turnoverRate":0.001674,"peRate":71.768844,"marketCap":45293401676,"floatMarketCap":42296909491,"timestamp":1787673858227,"nameCN":"避孕概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4584\",,,,undefined,":{"bkCode":"BK4584","up":3,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4584\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1125508200","title":"曼恩凱德生物醫療：售股股東擬最多拋售逾1285萬股，含逾241萬份認股權證股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1125508200","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125508200?lang=zh_tw&edition=fundamental","pubTime":"2026-08-22 04:08","pubTimestamp":1787342920,"startTime":"0","endTime":"0","summary":"曼恩凯德生物医疗日前提交美国证券交易委员会文件，披露一项重大股权变动计划——公司售股股东或将释放高达12,853,470股股票，值得注意的是，其中约2,412,632股源于认股权证行权所得股份。尤其值得关注的是，认股权证股份在其中所占的比重，为整体交易增添了复杂性与策略性考量。整体来看，此次SEC文件披露的信息，既反映了股东层面对公司股票流动性的管理策略，也为市场提供了关于未来股价走势的重要参考信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNKD","BK4139","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661935862","title":"市場消息：土耳其對梯瓦製藥發起反壟斷調查。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661935862","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661935862?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 21:06","pubTimestamp":1787317576,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4559","LU2324357040.USD","BK4588","TEVA","LU1983299246.USD","BK4557","BK4596","BK4566","BK4007","BK4584","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660421155","title":"梯瓦製藥的妥瑞氏綜合徵療法獲美國FDA優先審評","url":"https://stock-news.laohu8.com/highlight/detail?id=2660421155","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660421155?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 23:01","pubTimestamp":1787151678,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4566","BK4596","BK4584","LABU","BK4559","BK4007","TEVA","LU2324357040.USD","BK4557","LU1983299246.USD","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660423334","title":"梯瓦製藥的Ecopipam新藥申請獲得美國食品藥品監督管理局（FDA）優先審評資格。","url":"https://stock-news.laohu8.com/highlight/detail?id=2660423334","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660423334?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 20:31","pubTimestamp":1787142670,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","BK4559","BK4557","BK4588","LU2324357040.USD","BK4585","LABU","BK4596","BK4584","LU1983299246.USD","TEVA","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132499934","title":"Dare Bioscience 宣佈完成600萬美元註冊直接發行，按納斯達克規則市價定價","url":"https://stock-news.laohu8.com/highlight/detail?id=1132499934","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132499934?lang=zh_tw&edition=fundamental","pubTime":"2026-08-15 00:46","pubTimestamp":1786725969,"startTime":"0","endTime":"0","summary":"Dare Bioscience（股票代码：DARE）今日正式宣告，其此前披露的600万美元注册直接发行已顺利完成定价。此次发行严格遵循纳斯达克市场规则，采用市价发行机制。这笔资金将用于公司运营与研发推进，标志着公司在资本市场再获关键助力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4584","DARE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133368521","title":"Dare Bioscience 發布2026年第二季度財報：多產品女性健康戰略推進，商業拐點凸顯","url":"https://stock-news.laohu8.com/highlight/detail?id=1133368521","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133368521?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 04:02","pubTimestamp":1786651343,"startTime":"0","endTime":"0","summary":"Dare Bioscience（股票代码：DARE）近日公布了2026年第二季度业绩报告。报告显示，随着公司多产品女性健康战略的持续深入，其商业运营已迎来关键转折点。在本次财报中，公司不仅披露了当季财务数据，更着重强调了这一战略转型的积极信号。从产品线布局到市场拓展，种种迹象表明，这家专注于女性健康的生物科技企业正加速驶入商业化快车道。尽管具体数字尚待进一步分析，但“商业拐点”这一表述本身已足以引发市场对其未来增长潜力的无限遐想。在竞争激烈的女性健康赛道，Dare Bioscience 正凭借其多元化的产品组合，试图开辟出一条差异化的发展路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4584","DARE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105142491","title":"Femasys Inc：Maxim Group 將目標價從30美元下調至10美元，以反映1比20的反向股票分割","url":"https://stock-news.laohu8.com/highlight/detail?id=1105142491","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105142491?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 22:25","pubTimestamp":1786631147,"startTime":"0","endTime":"0","summary":"Femasys Inc 近期迎来重大调整。Maxim Group 已将其目标股价从30美元大幅下调至10美元。这一变动，旨在精准反映公司实施的1比20反向股票拆分动作。此举意味着，每20股现有股票将合并为1股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FEMY","BK4082","BK4539","BK4584"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}]}}